Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Medsol RX vs PeptidesRx

Medsol RX
Graded #306

Lower grade

vs+3.4000000000000057
PeptidesRx
Graded #240

Higher grade

The verdict

PeptidesRx takes it — 64.4/100 to 61/100.

PeptidesRx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. PeptidesRx is a Fort Worth, TX-based licensed telehealth platform offering physician-supervised compounded semaglutide, tirzepatide, and a broader prescription peptide menu.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valuePeptidesRx +17
45
62
Dose & formulationMedsol RX +10
64
54
Clinical oversightPeptidesRx +6
79
85
Labs & monitoringPeptidesRx +2
53
55
FulfillmentMedsol RX +13
83
70
Contract termsPeptidesRx +14
41
55
Medsol RX · left barPeptidesRx · right bar

The numbers

MetricMedsol RXPeptidesRx
WeighScore61/10064.4/100
GradeCC
Scorecard rank#306#240
Semaglutide$209/mo (compounded)$169/mo (0.25 mg dose, compounded)
Tirzepatide$250/mo (compounded)$309/mo (2.5 mg dose, compounded)
CoverageAll 50 statesCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
Medsol RX

Graded #306 · C

Strengths

  • Compounded semaglutide from $209/mo (12-mo plan) and tirzepatide from ~$250/mo; HSA/FSA eligible with Klarna financing
  • Every plan bundles the medication, a dedicated care coach, custom treatment plan, medical oversight, and free shipping
  • Board-certified clinicians via OpenLoop; same-day approvals; ships nationwide
  • Month-to-month option ($199 first month) with no long-term commitment, plus microdosing and wellness add-ons

Where it loses points

  • Doesn't name its compounding pharmacy (generic 'certified U.S. pharmacies')
  • No legal entity name published on the site
  • Tirzepatide pricing is given as a range ($250-$1,400/mo), not a fixed rate
  • Compounded GLP-1s are not FDA-approved (the site discloses this)
PeptidesRx

Graded #240 · C

Strengths

  • Compliance-focused positioning vs gray-market vendors
  • Board-certified medical director
  • Transparent pricing with no surprise fees
  • Real prescriptions, not research-chemical channel

Where it loses points

  • Smaller scale than Henry Meds or Hims
  • Wide peptide menu may distract from GLP-1 focus

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard